Results
4
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
4 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KIN | €37.10 | -5.1% | -16.8% | €991.6m | €54.15 | PE28x | E27.8% | 1.5% | Media | ||
SOLB | €32.10 | 4.9% | -70.6% | €3.3b | €33.31 | PS0.6x | E44.3% | 5.5% | Materials | ||
ARGX | €589.80 | 0.4% | 40.0% | €35.6b | €578.60 | PS19.6x | E55.4% | n/a | Pharmaceuticals & Biotech | ||
FLOB | €605.00 | 11.0% | -11.0% | €592.6m | €835.00 | PE386.3x | E48.2% | 0.4% | Food, Beverage & Tobacco |